The hyperglycemia-induced vascular leakage and melanoma cell metastasis were mitigated by inhibiting TGase2 through systemic supplementation of proinsulin C-peptide 4, insulin 26, or midazolam 89. The gene discussed is TGM2; the disease is Hyperglycemia.